Eric A Klein Selected Research

Vitamin E

10/2017	A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts.
12/2016	Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial.
1/2016	Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.
1/2015	Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial.
10/2014	Is there a role for body mass index in the assessment of prostate cancer risk on biopsy?
9/2014	Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
9/2014	A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
8/2014	Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.
3/2014	Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.
8/2013	Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric A Klein Research Topics

Disease

238	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 01/2002
126	Neoplasms (Cancer) 05/2022 - 01/2002
33	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2002
13	Disease Progression 01/2021 - 03/2004
12	Carcinoma (Carcinomatosis) 01/2020 - 10/2002
12	Margins of Excision 12/2014 - 07/2002
11	Infections 01/2022 - 08/2004
7	Adenocarcinoma 07/2019 - 04/2004
6	Extranodal Extension 12/2014 - 03/2004
5	Erectile Dysfunction 01/2018 - 12/2002
5	Renal Cell Carcinoma (Grawitz Tumor) 08/2015 - 02/2009
5	Retroviridae Infections (Infection, Retrovirus) 01/2012 - 10/2008
4	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022 - 03/2008
4	COVID-19 01/2022 - 10/2020
4	Carcinogenesis 09/2014 - 02/2004
3	Starvation 01/2020 - 07/2013
3	Breast Neoplasms (Breast Cancer) 06/2019 - 02/2008
3	7 Hereditary Prostate Cancer 01/2019 - 03/2006
3	Testicular Neoplasms (Testicular Cancer) 09/2010 - 11/2005
3	Nonseminomatous germ cell tumor 04/2008 - 08/2006
3	Lymphatic Metastasis 05/2007 - 03/2006
2	Urinary Incontinence 01/2017 - 12/2006
2	Cataract (Cataracts) 12/2016 - 01/2015
2	Prostatic Intraepithelial Neoplasia 11/2011 - 02/2004
2	Chronic Renal Insufficiency 09/2010 - 04/2010
2	Embryonal Carcinoma 11/2009 - 04/2008
2	Virus Diseases (Viral Diseases) 07/2009 - 05/2008
2	Pathologic Complete Response 02/2009 - 09/2007

Drug/Important Bio-Agent (IBA)

59	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 08/2002
32	AndrogensIBA 01/2022 - 03/2004
26	SeleniumIBA 10/2017 - 01/2003
24	Vitamin E FDA LinkGeneric 10/2017 - 01/2003
23	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2010
19	Biological ProductsIBA 09/2019 - 04/2005
11	DNA (Deoxyribonucleic Acid)IBA 07/2021 - 01/2004
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2006
9	Finasteride (Propecia)FDA LinkGeneric 10/2017 - 12/2003
6	EnzymesIBA 01/2021 - 02/2004
6	RNA (Ribonucleic Acid)IBA 11/2018 - 07/2009
6	Docetaxel (Taxotere)FDA Link 04/2015 - 01/2003
5	Protein Isoforms (Isoforms)IBA 01/2022 - 12/2011
5	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2007
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2019 - 11/2009
5	2-5A-dependent ribonuclease (RNase L)IBA 01/2011 - 10/2003
5	Antiviral Agents (Antivirals)IBA 01/2011 - 10/2003
4	AntigensIBA 12/2021 - 08/2002
4	CytokinesIBA 01/2021 - 09/2002
4	Dihydrotachysterol (AT 10)IBA 04/2016 - 03/2002
3	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 05/2007
3	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2016
3	SteroidsIBA 01/2021 - 01/2019
3	enzalutamideIBA 01/2021 - 01/2016
3	Phosphates (Orthophosphate)IBA 01/2020 - 07/2013
3	Indicators and Reagents (Reagents)IBA 01/2019 - 10/2013
3	Messenger RNA (mRNA)IBA 01/2019 - 09/2002
3	Pharmaceutical PreparationsIBA 04/2016 - 01/2007
2	Cell-Free Nucleic AcidsIBA 07/2021 - 01/2021
2	Biological FactorsIBA 01/2021 - 09/2015
2	ErbB Receptors (EGF Receptor)IBA 06/2019 - 02/2008
2	Epidermal Growth Factor (EGF)IBA 06/2019 - 02/2008
2	Testosterone (Sustanon)FDA Link 01/2019 - 12/2008
2	Hormones (Hormone)IBA 01/2019 - 09/2010
2	TristetraprolinIBA 01/2019 - 11/2018
2	InterferonsIBA 11/2018 - 05/2008
2	A-Form DNA (A-DNA)IBA 01/2018 - 04/2016
2	Dihydrotestosterone (Androstanolone)IBA 10/2017 - 10/2016
2	UbiquitinIBA 01/2017 - 01/2017
2	hydroxide ionIBA 10/2016 - 03/2004
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2016 - 08/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2016 - 08/2015
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2015 - 01/2013
2	Selenomethionine (Sethotope)FDA Link 09/2014 - 11/2011
2	AntioxidantsIBA 09/2014 - 02/2004
2	A 17 (A-17)IBA 03/2014 - 04/2012
2	CholesterolIBA 02/2013 - 11/2009
2	AntibodiesIBA 08/2010 - 03/2006
2	Sunitinib (Sutent)FDA Link 09/2009 - 02/2009
2	Thalidomide (Thalomid)FDA Link 05/2008 - 03/2005

Therapy/Procedure

119	Prostatectomy (Retropubic Prostatectomy) 11/2022 - 08/2002
53	Radiotherapy 01/2021 - 03/2002
50	Therapeutics 01/2022 - 03/2002
27	Brachytherapy 01/2022 - 01/2003
15	Chemoprevention 01/2018 - 01/2002
10	Lymph Node Excision (Lymph Node Dissection) 09/2010 - 03/2004
9	Drug Therapy (Chemotherapy) 09/2010 - 07/2003
7	Neoadjuvant Therapy 10/2022 - 01/2003
7	Nephrectomy 08/2015 - 01/2002
6	Castration 01/2022 - 04/2009
5	Cystectomy 10/2022 - 10/2004
5	Aftercare (After-Treatment) 01/2012 - 10/2002
4	Salvage Therapy 11/2016 - 05/2007
4	Orchiectomy (Orchidectomy) 04/2008 - 11/2002
3	Adjuvant Radiotherapy 04/2014 - 10/2005
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 03/2008 - 12/2005
2	Length of Stay 01/2022 - 07/2002
2	Blood Transfusion (Blood Transfusions) 01/2022 - 02/2011
2	Time-to-Treatment 01/2019 - 01/2019
2	Precision Medicine 10/2015 - 02/2014
2	Treatment Delay 01/2013 - 04/2009
2	Diet Therapy (Therapy, Diet) 02/2010 - 01/2002